|
IQCB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85880000280747E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.27960000268135E-08 |
| Normal-vs-Stage2 |
6.206900E-04 |
| Normal-vs-Stage3 |
1.475970E-03 |
| Normal-vs-Stage4 |
4.004700E-04 |
| Stage1-vs-Stage2 |
8.953200E-01 |
| Stage1-vs-Stage3 |
1.875960E-01 |
| Stage1-vs-Stage4 |
7.847000E-01 |
| Stage2-vs-Stage3 |
3.281000E-01 |
| Stage2-vs-Stage4 |
7.665600E-01 |
| Stage3-vs-Stage4 |
4.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51870000411714E-08 |
| Normal-vs-AfricanAmerican |
6.496900E-03 |
| Normal-vs-Asian |
1.562320E-03 |
| Caucasian-vs-AfricanAmerican |
2.898200E-01 |
| Caucasian-vs-Asian |
5.245000E-01 |
| AfricanAmerican-vs-Asian |
2.359000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35239999999415E-05 |
| Normal-vs-Female |
2.95130031524593E-10 |
| Male-vs-Female |
1.080160E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.707700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.495500052914E-09 |
| Normal-vs-Age(61-80Yrs) |
1.64995999999418E-05 |
| Normal-vs-Age(81-100Yrs) |
2.427800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.143800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.057600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.346180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.068790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.714400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.454400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.221800E-03 |
| Normal-vs-Grade 2 |
1.99550043156194E-10 |
| Normal-vs-Grade 3 |
2.207400E-04 |
| Normal-vs-Grade 4 |
3.810500E-02 |
| Grade 1-vs-Grade 2 |
2.625400E-01 |
| Grade 1-vs-Grade 3 |
1.257900E-02 |
| Grade 1-vs-Grade 4 |
3.442000E-02 |
| Grade 2-vs-Grade 3 |
1.384790E-03 |
| Grade 2-vs-Grade 4 |
1.224160E-02 |
| Grade 3-vs-Grade 4 |
6.941000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.11075601441735E-12 |
| Normal-vs-ccB subtype |
1.125610E-02 |
| ccA subtype-vs-ccB subtype |
6.98540000287906E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.50140000326959E-08 |
| Normal-vs-N1 |
4.403700E-02 |
| N0-vs-N1 |
4.990400E-01 |
|
|
